Jane Street
CRL icon

Jane Street’s Charles River Laboratories CRL Stock Holding History

Jane Street’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Buy
+8,600
New +$1.59M ﹤0.01% 5671
2025
Q4 		– Sell
-2,500
Closed -$391K – 11296
2025
Q3 		$391K Sell
2,500
-45,500
-95% -$7.23M ﹤0.01% 8367
2025
Q2 		$7.28M Buy
48,000
+19,600
+69% +$2.61M ﹤0.01% 2530
2025
Q1 		$4.27M Sell
28,400
-23,100
-45% -$3.87M ﹤0.01% 3166
2024
Q4 		$9.51M Sell
51,500
-1,500
-3% -$289K ﹤0.01% 1933
2024
Q3 		$10.4M Buy
53,000
+1,300
+3% +$270K ﹤0.01% 1867
2024
Q2 		$10.7M Buy
51,700
+50,700
+5,070% +$11.5M ﹤0.01% 1979
2024
Q1 		$271K Buy
+1,000
New +$239K ﹤0.01% 7718
2023
Q4 		– Sell
-3,100
Closed -$608K – 9248
2023
Q3 		$608K Buy
+3,100
New +$636K ﹤0.01% 5982
2023
Q2 		– Sell
-16,900
Closed -$3.41M – 8788
2023
Q1 		$3.41M Buy
16,900
+11,700
+225% +$2.65M ﹤0.01% 2973
2022
Q4 		$1.13M Buy
+5,200
New +$1.14M ﹤0.01% 4783
2022
Q2 		– Sell
-3,400
Closed -$965K – 9782
2022
Q1 		$965K Sell
3,400
-200
-6% -$61.7K ﹤0.01% 6212
2021
Q4 		$1.36M Sell
3,600
-24,500
-87% -$9.52M ﹤0.01% 5295
2021
Q3 		$11.6M Buy
28,100
+16,000
+132% +$6.64M ﹤0.01% 1621
2021
Q2 		$4.48M Buy
12,100
+6,600
+120% +$2.2M ﹤0.01% 2837
2021
Q1 		$1.59M Sell
5,500
-1,200
-18% -$334K ﹤0.01% 4461
2020
Q4 		$1.67M Sell
6,700
-4,500
-40% -$1.07M ﹤0.01% 3810
2020
Q3 		$2.54M Buy
11,200
+4,600
+70% +$955K ﹤0.01% 2680
2020
Q2 		$1.15M Buy
+6,600
New +$1.05M ﹤0.01% 3862

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jane Street's CRL Position: Q1 2026 in Review

Jane Street increased its Charles River Laboratories (CRL) stake by 1.2% in Q1 2026, buying an estimated $4.63K and bringing the position to 2,034 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #8872.

Jane Street first reported a position in CRL in Q2 2013 and has held it in 39 quarters since. The position peaked at $20.7M in Q1 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Jane Street held 2,034 shares of Charles River Laboratories worth $351K as of Q1 2026.
  • Jane Street bought 25 Charles River Laboratories shares in Q1 2026, an estimated $4.63K.
  • Charles River Laboratories made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8872 holding.
  • Jane Street first reported a position in Charles River Laboratories in Q2 2013 and has held it in 39 quarters since.
  • Jane Street's Charles River Laboratories position peaked at $20.7M in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.